|
三生制葯, 01530.HK - 綜合損益表 |
2023-12 |
2022-12 |
2021-12 |
2020-12 |
2019-12 |
2018-12 |
2017-12 |
2016-12 |
2015-12 |
2014-12 |
2013-12 |
2012-12 |
營業額 |
7,815,938 |
6,859,433 |
6,382,009 |
5,587,636 |
5,318,091 |
4,583,869 |
3,734,334 |
2,797,289 |
1,673,126 |
1,130,854 |
875,396 |
656,145 |
經營溢利 |
2,009,307 |
2,305,125 |
1,902,689 |
1,008,997 |
1,239,014 |
1,503,756 |
1,116,459 |
862,250 |
584,008 |
361,567 |
213,284 |
130,571 |
非經營/ 特殊項目 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
聯營公司 |
-30,848 |
-31,092 |
-33,923 |
-29,868 |
-16,001 |
-8,245 |
-14,442 |
-12,182 |
3,848 |
-1,383 |
-4,576 |
-165 |
除稅前經營溢利 |
1,978,459 |
2,274,033 |
1,868,766 |
979,129 |
1,223,013 |
1,495,511 |
1,102,017 |
850,068 |
587,856 |
360,184 |
208,708 |
130,406 |
稅項 |
392,167 |
366,016 |
241,193 |
208,023 |
242,785 |
218,265 |
177,613 |
135,814 |
61,626 |
68,456 |
112,649 |
28,519 |
少數股東權益 |
37,053 |
-6,868 |
-23,674 |
-64,685 |
6,511 |
79 |
-10,985 |
1,690 |
-50 |
0 |
167 |
221 |
股東應占溢利 |
1,549,239 |
1,914,885 |
1,651,247 |
835,791 |
973,717 |
1,277,167 |
935,389 |
712,564 |
526,280 |
291,728 |
95,892 |
101,666 |
貨幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
單位 |
主要項目 |
折舊 |
334,848 |
366,106 |
329,002 |
360,937 |
333,968 |
313,264 |
243,695 |
161,000 |
77,363 |
33,490 |
40,001 |
30,485 |
利息 |
212,296 |
101,053 |
66,525 |
81,066 |
109,476 |
138,382 |
141,350 |
147,710 |
26,545 |
29,182 |
0 |
0 |
利息撥作發展資本 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
處置/重估固定資產 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
稅率(%) |
19.82 |
16.1 |
12.91 |
21.25 |
19.85 |
14.59 |
16.12 |
15.98 |
10.48 |
19.01 |
53.97 |
21.87 |
營業額增長(%) |
13.94 |
7.48 |
14.22 |
5.07 |
16.02 |
22.75 |
33.5 |
67.19 |
47.95 |
29.18 |
33.42 |
0.0 |
股東應占溢利增長(%) |
-19.09 |
15.97 |
97.57 |
-14.16 |
-23.76 |
36.54 |
31.27 |
35.4 |
80.4 |
204.23 |
-5.68 |
0.0 |
核數師意見 |
0 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
0 |
0 |
0 |
說明:1代表無保留意見;2代表保留意見;3代表修改意見
|
|